Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01391910 · ClinicalTrials.gov registry record
Response Shift in Sinus Surgery Outcomes
A clinical trial, sponsored by Greg Davis.
- Completed
- Registry status
- 32
- Enrollment target
NCT01391910: Completed study, sponsored by Greg Davis.
NCT01391910 is a clinical trial that has completed, run by Greg Davis. The registered enrollment target is 32 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01391910 has completed, sponsored by Greg Davis.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The aims of the study are: 1)to assess pre and post-operative Quality of Life (QOL) as measured by the Sino-Nasal Outcomes Test(SNOT)-20 questionnaire and 2)determine the significance of response shift on treatment effect. This is a prospective cohort study. The investigators will recruit patients who are within a 6 month post-functional endoscopic sinus surgery (FESS) timeframe and completed a pre-operative SNOT-20. The investigators will ask subjects to complete two more SNOT-20 forms and a Transition Quality of Life (QOL) scale. The SNOT-20 forms will be labelled "pre" and "post" operative. The "pre" should be completed based on subject's memory of their condition prior to surgery and "post" based on how they feel now.
Primary Outcome
The SNOT-20 "pre" and "post" surgery will be compared to the pre-surgery SNOT-20
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-06 |
What the finished NCT01391910 record still lists
NCT01391910 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 32 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01391910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01391910 about?
NCT01391910 is a clinical study titled "Response Shift in Sinus Surgery Outcomes". The aims of the study are: 1)to assess pre and post-operative Quality of Life (QOL) as measured by the Sino-Nasal Outcomes Test(SNOT)-20 questionnaire and 2)determine the significance of response shift on treatment effect. This is a prospective cohort study. The investigators will recruit patients ...
What is the current status of trial NCT01391910?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2011-06. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01391910?
This trial is sponsored by Greg Davis, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia